| Sanofi-Aventis (Suisse) SA - Adacel 0.5 ml, suspension injectable en seringue préremplie | | 68317 | | 01 | | Adacel 0.5 ml | | suspension injectable en seringue préremplie | | J07AJ52 | | Pertussis, Purified Antigen, Combinations with Toxoids | | 26.08.2022 | | |
| | Composition | | toxoidum diphtheriae min. 2 U.I., toxoidum tetani min. 20 U.I., toxoidum pertussis 2.5 µg, haemagglutininum filamentosum 5 µg, pertactinum 3 µg, fimbriae types 2 et 3 5 µg, aluminii phosphas corresp. aluminium 0.33 mg, phenoxyethanolum, aqua ad iniectabile, ad suspensionem pro 0.5 ml, residui: formaldehydum, glutaralum. | | Packungsbestandteile | | | |
|
